Researchers say drug improved survival among COVID-19 patients in 'major breakthrough'
An inexpensive drug looks to be able to improve survival odds for COVID-19 patients with "severe respiratory complications," according to a new study.
Researchers on Tuesday announced the results of a study in which 2,104 patients received dexamethasone, a steroid, and 4,321 patients received usual care, The Associated Press reports. The drug reduced deaths by one-third for patients who were on ventilators and one-fifth for patients who were receiving oxygen, they said.
However, the study didn't show a benefit to patients "who did not require respiratory support," according to the announcement.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"This is an extremely welcome result," University of Oxford's Peter Horby, one of the chief investigators on the study, said in a statement. "The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients. Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide."
Horby also described dexamethasone, which BBC News reports is "already used to reduce inflammation in a range of other conditions," as the "first drug to be shown to improve survival in COVID-19" and told Reuters this is a "major breakthrough." Still, Axios notes the results of this trial "have not been peer-reviewed, or published formally at all." The researchers said the details will be published "as soon as possible."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Will Iran's attack on Israel backfire?
Today's Big Question The unprecedented targeting of Israel could be a 'godsend' for Netanyahu as the limits of Tehran's military power are exposed
By Elliott Goat, The Week UK Published
-
Tuck in to British fusion cuisine
The Week Recommends The trend for combining classics from two food cultures can result in dishes that are doubly delicious
By The Week UK Published
-
Labour and nuclear weapons: a turbulent ideological history
The Explainer From the 1940s to Keir Starmer, the party leadership has zigzagged in and out of love with the bomb
By Chas Newkey-Burden, The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published